CSI Market
Sign In | Register

Cell Source Inc (CLCS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CLCS quarterly Cash Flow →
Observing cash flow movements over recent quarters helps explain how Cell Source Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Operating Activities
Income-4.51
Depreciation & amortization0.00
Amortization of Other Assets0.16
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.25
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.02
Accretion Of Discount-
Coupon Interest Expense-
Adjustments To Additional Paid In Capital Warrant Issued-
Loss On Exchange Of Notes Payable For Preferred Shares-
Increase Decrease In Accrued Liabilities Related Parties-
Accrued Interest Related Parties-
Debt Instrument Amortization Of Debt Discount-
Loss On Exchange Of Warrants For Common Shares-
Warrant Modification Expense0.00
Debt Instrument Decrease Forgiveness-
Increase Decrease In Accrued Expenses Related Parties-
Gain On Forgiveness Of Accrued Expenses-
Gain On Exchange Of Accrued Interest For Common Stock-
Gain Loss On Derivative Instruments Net Pretax-
Gain On Forgiveness Of Accrued Interest-
Extinguishment Of Debt Amount-
Derivative Gain Loss On Derivative Net-0.35
Gain Loss Related To Litigation Settlement-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities0.00
Increase (Decrease) in Accounts Payable0.42
Accrued Expense0.07
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.32
Other Working Capital0.18
Other Noncash Income (Expense)-0.14
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.93
Discontinued operations0.00
Net Cash flow from Operating Activities-2.68
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Collection of Advance to Affiliate0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.45
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.01
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net1.59
Proceeds From Issuance Of Common Stock And Warrants Net-
Proceeds From Issuance Of Common Stock And Warrants0.64
Proceeds From Issuance Of Notes Payable Related Party-
Proceeds From Notes Payable Related Party-
Proceeds From Cash Advances-
Proceeds From Advances Payable0.06
Payment Of Equity Issuance Costs-
Repayment Of Advances Payable-
Proceeds From Issuance Of Convertible Notes Payable-
Warrants And Conversion Options Issued In Connection With Issuance And Extension Of Notes Payable-
Warrants Issued In Connection With Issuance Of Advance Payable-
Preferred Stock Issued In Exchange For-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.74
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-2.68
Total Cash Flow0.05
4 historic quarters locked

Sign in to unlock the full Cell Source Inc cash flow history.

Sign In Create Free Account

About Cell Source Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: April 6, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-015359

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document